Arcellx

Job cuts employee layoffs firings or downsizing Scissors dividing individuals positioned on colorful blocks

Biotech

After buyout, Gilead is laying off Arcellx staff on both coasts

With Gilead's $7.8 billion buyout of Arcellx complete, the California pharma is consolidating some of the workforce at the acquired company.

Fraiser Kansteiner May 5, 2026 3:12pm

Fully set dinner table

After 3 acquisitions, Gilead shifts focus to expanded pipeline

Apr 8, 2026 4:00am

Glowing puzzle piece fitting into puzzle

Gilead inks $8B Arcellx buyout to steer CAR-T into J&J showdown

Feb 23, 2026 7:30am

Gilead and Kites exhibit booth at ASH 2025

ASH: Anito-cel strengthens potential as Kite preps for launch

Dec 7, 2025 11:52am

Legend

Fierce Pharma

J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T

Nov 12, 2025 11:36am

Rendering of an immune cell

ASH: Gilead-Arcellx data build CAR-T's case in advanced myeloma

Nov 5, 2024 3:08pm